About Makerere University
Makerere University, Kampala; Makerere University is Uganda's largest and oldest institution of higher learning, first established as a technical school in 1922. It became an independent national university in 1970.
Clinical Trials at Makerere University
During the past decade, Makerere University conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Makerere University" #1 sponsor was "Makerere University" with 5 trials, followed by "University of California, San Francisco" with 3 trials
sponsored, "Amsterdam Institute for Global Health and Development" with 1 trials sponsored, "Barcelona Institute for Global Health" with 1 trials sponsored and "International Maternal Pediatric Adolescent AIDS Clinical Trials Group"
with 1 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Makerere University"
#1 collaborator was "Makerere University" with 14 trials as a collaborator, "Amsterdam Institute for Global Health and Development" with 2 trials as a collaborator, "Centro de Investigacao em Saude de Manhica" with 2 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator and "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 2 trials as a collaborator. Other collaborators include 37 different institutions and companies that were
collaborators in the rest 46 trials.
Clinical Trials Conditions at Makerere University
According to Clinical.Site data, the most researched conditions in "Makerere University" are
"Tuberculosis" (4 trials), "HIV Infections" (2 trials), "Malaria" (2 trials), "Stunting" (2 trials) and "Wasting" (2 trials). Many other conditions were trialed in "Makerere University" in a lesser frequency.
Clinical Trials Intervention Types at Makerere University
Most popular intervention types in "Makerere University" are "Behavioral" (9 trials), "Drug" (4 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "ART" (1 trials), "Behavioral" (1 trials), "Community pilot L-PZQ distribution - intervention is NOT part of this observational study" (1 trials), "Computerised cognitive rehabilitation training" (1 trials) and "Cough sounds" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Makerere University
The vast majority of trials in "Makerere University" are
19 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Makerere University
Currently, there are NaN active trials in "Makerere University".
undefined are not yet recruiting,
6 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 13 completed trials in Makerere University,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Makerere University, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 10 trials that are defined as “Not Applicable".
Departments of Makerere University
Makerere University has several departments that took part in Clinical trials: "Infectious Diseases Institute" - 57 trials, "Department of Paediatrics and Child Health, Makerere University" - 5 trials, "Infectious Diseases Institute Kasangati" - 4 trials, "Department of Surgery, Makerere University College of Health Sciences" - 2 trials